These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

145 related articles for article (PubMed ID: 37034517)

  • 1. Long non-coding RNA LINC00336 as an independent prognostic indicator and an oncogenic lncRNA in bladder cancer.
    Guo X; Liu N; Liu M
    Arch Med Sci; 2023; 19(2):478-487. PubMed ID: 37034517
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A panel of 8-lncRNA predicts prognosis of breast cancer patients and migration of breast cancer cells.
    Zhu L; Cui K; Weng L; Yu P; Du Y; Zhang T; Liu H; Li B; Ma W
    PLoS One; 2021; 16(6):e0249174. PubMed ID: 34086679
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Long non-coding RNA ARAP1-AS1 promotes the progression of bladder cancer by regulating miR-4735-3p/NOTCH2 axis.
    Teng J; Ai X; Jia Z; Wang K; Guan Y; Guo Y
    Cancer Biol Ther; 2019; 20(4):552-561. PubMed ID: 30404578
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Microarray expression profiles analysis revealed lncRNA OXCT1-AS1 promoted bladder cancer cell aggressiveness via miR-455-5p/JAK1 signaling.
    Chen JB; Zhu YW; Guo X; Yu C; Liu PH; Li C; Hu J; Li HH; Liu LF; Chen MF; Chen HQ; Xiong-Bing Z
    J Cell Physiol; 2019 Aug; 234(8):13592-13601. PubMed ID: 30609030
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Silenced lncRNA SNHG14 restrains the biological behaviors of bladder cancer cells via regulating microRNA-211-3p/ESM1 axis.
    Feng R; Li Z; Wang X; Ge G; Jia Y; Wu D; Ji Y; Wang C
    Cancer Cell Int; 2021 Jan; 21(1):67. PubMed ID: 33482820
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The high expression of long non-coding RNA PANDAR indicates a poor prognosis for colorectal cancer and promotes metastasis by EMT pathway.
    Lu M; Liu Z; Li B; Wang G; Li D; Zhu Y
    J Cancer Res Clin Oncol; 2017 Jan; 143(1):71-81. PubMed ID: 27629879
    [TBL] [Abstract][Full Text] [Related]  

  • 7. LncRNA AFAP1-AS1 promotes proliferation ability and invasiveness of bladder cancer cells.
    Gui JQ; Zhang C; Yang HB; Yu YW; Cui MR; Wang WS
    Eur Rev Med Pharmacol Sci; 2020 Sep; 24(17):8747-8755. PubMed ID: 32964963
    [TBL] [Abstract][Full Text] [Related]  

  • 8. NOTCH1 regulates the proliferation and migration of bladder cancer cells by cooperating with long non-coding RNA HCG18 and microRNA-34c-5p.
    Xu Z; Huang B; Zhang Q; He X; Wei H; Zhang D
    J Cell Biochem; 2019 Apr; 120(4):6596-6604. PubMed ID: 30426533
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Long noncoding RNA LINC00336 inhibits ferroptosis in lung cancer by functioning as a competing endogenous RNA.
    Wang M; Mao C; Ouyang L; Liu Y; Lai W; Liu N; Shi Y; Chen L; Xiao D; Yu F; Wang X; Zhou H; Cao Y; Liu S; Yan Q; Tao Y; Zhang B
    Cell Death Differ; 2019 Nov; 26(11):2329-2343. PubMed ID: 30787392
    [TBL] [Abstract][Full Text] [Related]  

  • 10. LncRNA AK023391 promotes tumorigenesis and invasion of gastric cancer through activation of the PI3K/Akt signaling pathway.
    Huang Y; Zhang J; Hou L; Wang G; Liu H; Zhang R; Chen X; Zhu J
    J Exp Clin Cancer Res; 2017 Dec; 36(1):194. PubMed ID: 29282102
    [TBL] [Abstract][Full Text] [Related]  

  • 11. LncRNA CALML3-AS1 promotes tumorigenesis of bladder cancer via regulating ZBTB2 by suppression of microRNA-4316.
    Wang F; Zu Y; Huang W; Chen H; Xie H; Yang Y
    Biochem Biophys Res Commun; 2018 Sep; 504(1):171-176. PubMed ID: 30177388
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Long non-coding RNA taurine-upregulated gene 1 predicts unfavorable prognosis, promotes cells proliferation, and inhibits cells apoptosis in epithelial ovarian cancer.
    Li TH; Zhang JJ; Liu SX; Chen Y
    Medicine (Baltimore); 2018 May; 97(19):e0575. PubMed ID: 29742691
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Cytoskeleton regulator RNA expression on cancer-associated fibroblasts is associated with prognosis and immunotherapy response in bladder cancer.
    Wu Y; Xu Y; He S; Li Y; Feng N; Fan J; Gong Y; Li X; Zhou L
    Heliyon; 2023 Mar; 9(3):e13707. PubMed ID: 36873531
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Up-regulation of long non-coding RNA PANDAR is associated with poor prognosis and promotes tumorigenesis in bladder cancer.
    Zhan Y; Lin J; Liu Y; Chen M; Chen X; Zhuang C; Liu L; Xu W; Chen Z; He A; Zhang Q; Sun X; Zhao G; Huang W
    J Exp Clin Cancer Res; 2016 May; 35(1):83. PubMed ID: 27206339
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Up-regulation of the long non-coding RNA RMRP contributes to glioma progression and promotes glioma cell proliferation and invasion.
    Feng W; Li L; Xu X; Jiao Y; Du W
    Arch Med Sci; 2017 Oct; 13(6):1315-1321. PubMed ID: 29181061
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Starvation-induced long non-coding RNAs are significant for prognosis evaluation of bladder cancer.
    Zhang C; Bai X; Peng X; Shi W; Li Y; Chen G; Yu H; Feng Z; Deng Y
    Aging (Albany NY); 2022 Dec; 14(24):10067-10080. PubMed ID: 36541918
    [TBL] [Abstract][Full Text] [Related]  

  • 17. LncRNA ITGB1 promotes the development of bladder cancer through regulating microRNA-10a expression.
    Dai L; Chai CM; Shen TY; Tian Y; Shang ZQ; Niu YJ
    Eur Rev Med Pharmacol Sci; 2019 Aug; 23(16):6858-6867. PubMed ID: 31486485
    [TBL] [Abstract][Full Text] [Related]  

  • 18. LINC00319-Mediated miR-3127 Repression Enhances Bladder Cancer Progression Through Upregulation of RAP2A.
    Wang X; Meng R; Hu QM
    Front Genet; 2020; 11():180. PubMed ID: 32194636
    [TBL] [Abstract][Full Text] [Related]  

  • 19. LncRNA TP73-AS1 predicts the prognosis of bladder cancer patients and functions as a suppressor for bladder cancer by EMT pathway.
    Tuo Z; Zhang J; Xue W
    Biochem Biophys Res Commun; 2018 May; 499(4):875-881. PubMed ID: 29625110
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The long non-coding RNA AK001796 contributes to poor prognosis and tumor progression in hepatocellular carcinoma.
    Han QL; Chen BT; Zhang KJ; Xia ST; Zhong WW; Zhao ZM
    Eur Rev Med Pharmacol Sci; 2019 Mar; 23(5):2013-2019. PubMed ID: 30915744
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.